Crews Bank & Trust’s Acrivon Therapeutics ACRV Stock Holding History

Crews Bank & Trust’s Portfolio ACRV Stock Details ACRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86K	Buy	+1,044	New	+$1.77K	﹤0.01%	637

Other funds holding ACRV

AWM

AAF Wealth Management Westborough, Massachusetts $271M AUM 24.26% 1-Year Est. Return

Crews Bank & Trust's ACRV Position: Q2 2026 in Review

Crews Bank & Trust opened a new position in Acrivon Therapeutics (ACRV) in Q2 2026: 1,044 shares worth $1.86K. The stake represents ﹤0.01% of the portfolio and ranks #637 among its holdings.

2 funds tracked by Wall St. Rank hold ACRV as of Q2 2026.

Crews Bank & Trust held 1,044 shares of Acrivon Therapeutics worth $1.86K as of Q2 2026.
Acrivon Therapeutics was a new Crews Bank & Trust position in Q2 2026.
Acrivon Therapeutics made up ﹤0.01% of Crews Bank & Trust's portfolio in Q2 2026, its #637 holding.
2 funds tracked by Wall St. Rank held Acrivon Therapeutics as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.